OBI Pharma Inc. to attend the investor conference on new drug development, hosted by Masterlink Securities

Capital increase for new shares to transfer to AP Biosciences, Inc.

OBI Pharma Inc. to attend the 36th J.P. Morgan Annual Healthcare Conference

OBI Pharma Inc. to attend Citi's 2017 Global Healthcare Conference

OBI Pharma Inc. to attend the 2017 Asia Pacific Healthcare Forum, hosted by Goldman Sachs

SFIPC and OBI jointly agreed to withdraw the proceedings on Civil case regarding the dismissal of the Chairman of the company.

OBI Plans to Issue New Shares in Exchange for the AP Biosciences, Inc. Shares Owned by AbProtix,Inc, Subject to Regulatory Approval

Announcement on Change of the Accounting Officer

USPTO Approved the Patent Application for OBI-888 "Antibodies, pharmaceutical compositions and uses thereof"

Contract Signing with Pharmacore for the Contract Manufacturing of OBI-858